Citations

Clear

6273 citation(s) found for "To, Andrew".

Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management
Vivian, Elaina , Cler, Leslie, Conwell, Darwin L. , Coté, Gregory A. , Dickerman, Richard, Freeman, Martin L. , Gardner, Timothy B. , Hawes, Robert H. , Kedia, Prashant , Krishnamoorthi, Rajesh , Oduor, Hellen , Ross, Andrew , Sethi, Amrita , Varadarajulu, Shyam , Vege, Santhi Swaroop , Wassef, Wahid , Wilcox, C. Mel, Yadav, Dhiraj , Ellison, Ashton , Habash, Samar, Rastegari, Sheila , Reddy, Rathan , Yen, Timothy , Tarnasky, Paul R., Pandol, Stephen J. , Papachristou, Georgios I. , Whitcomb, David C. , Wu, Bechien U. , Brooks, Mary Rachel

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 8 | Pages: 1322-1342

10.14309/ajg.0000000000000264 | PMID 31205135 Get It

INTRODUCTION: Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. METHODS: A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. RESULTS: Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. DISCUSSION: Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.
Gastrointestinal Manifestations of Rheumatological Diseases
Tolaymat, Omar , Abril, Andy , Lacy, Brian E. , Tolaymat, Omar A, Bowman, Andrew W. , Kröner, Paul T.

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 9 | Pages: 1441-1454

10.14309/ajg.0000000000000260 | PMID 31205138 Get It

Rheumatological diseases (RDs) represent a diverse group of diseases that are inherited or related to environmental factors. RDs frequently affect the gastrointestinal (GI) tract, and gastroenterologists are often asked to evaluate patients with symptoms thought to represent an underlying or coexisting RD. GI manifestations of RDs vary based on the organ involved as well as the extent and duration of involvement. Although most manifestations of RD are nonspecific and not life-threatening, the chronicity and severity of symptoms can be debilitating and may lead to serious injury. This narrative review discusses the most common RD encountered by gastroenterologists: systemic lupus erythematosus, systemic sclerosis (scleroderma), dermatomyositis/polymyositis, rheumatoid arthritis, Sjögren syndrome, overlap syndromes, mixed connective tissue disease, Ehlers-Danlos syndromes, and other vasculitides. Each section begins with a brief overview of the condition, followed by a discussion of the etiopathophysiology, physical examination findings, GI manifestations, diagnostic tools (i.e., serologic, imaging, endoscopic, and functional), and treatment options.
PD-1 hi CD8 + resident memory T cells balance immunity and fibrotic sequelae
Wang, Zheng , Wang, Shaohua , Goplen, Nick P., Li, Chaofan , Cheon, In Su , Dai, Qigang , Huang, Su, Shan, Jinjun , Ma, Chaoyu , Ye, Zhenqing , Xiang, Min , Porquera, Eva-Carmona, Kohlmeier, Jacob E. , Kaplan, Mark H. , Johnson, Aaron J. , Vassallo, Robert , Kohlmeier, Jacob E , Kaplan, Mark H , Zhang, Nu , Johnson, Aaron J. , Vassallo, Robert , Sun, Jie , Li, Chaofan , Dai, Qigang , Limper, Andrew H. , Porquera, E.M. Carmona, Sun, Jie

Mayo Clinic

Science Immunology | June 14, 2019 | Volume: 4 | Issue: 36 | Pages: No page available

10.1126/sciimmunol.aaw1217 | PMID 31201259 Get It

Exhausted-like CD8 + resident memory T cells in the lung limit immune activation–driven fibrosis.
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Rashidi, Armin , Hamadani, Mehdi , Zhang, Mei-Jie , Wang, Hai-Lin, Abdel‐Azim, Hisham , Aljurf, Mahmoud , Assal, Amer , Bashey, Asad, Beitinjaneh, Amer , Bejanyan, Nelli , Bolaños‐Meade, Javier , Byrne, Michael , Cahn, Jean‐Yves, Cairo, Mitchell S. , Ciurea, Stefan O. , Copelan, Edward A. , Daly, Andrew , Diaz, Miguel-Angel, Farhadfar, Nosha , Ganguly, Siddhartha , Hahn, Theresa , Hashmi, Shahrukh K. , Hildebrandt, Gerhard , Holland, H. Kent, Hossain, Nasheed , Kanakry, Christopher G. , Kharfan‐Dabaja, Mohamed A. , Khera, Nandita , Martino, Rodrigo , Munker, Reinhold , Murthy, Hemant S. , Nakamura, Ryotaro , Nathan, Sunita , Palmisiano, Neil , Patel, Sagar S. , Pidala, Joseph, Olin, Rebecca L. , Olsson, Richard F. , Ringdén, Olle , Rizzieri, David A. , Rowe, Jacob M. , Savoie, Mary Lynn , Seo, Sachiko , Shaffer, Brian C. , Singh, Anurag K. , Solh, Melhem , Stockerl‐Goldstein, Keith , Verdonck, Leo F. , Wagner, John L. , Waller, Edmund K. , Litzow, Mark R. , Weisdorf, Dan, Saber, Wael , Weisdorf, Daniel J. , Wagner, John E. , Gale, Robert P , Hashmi, Shahrukh K , Hildebrandt, Gerhard C , Kharfan-Dabaja, Mohamed A., McGuirk, Joseph , Murthy, Hemant S , Nishihori, Taiga , Patel, Sagar , Olsson, Richard F , Ringden, Olov , Savoie, Mary Lynn , Wagner, John , Waller, Edmund K , Sandmaier, Brenda M , Litzow, Mark R. , Weisdorf, Dan , Hamadani, Mehdi , Assal, Amer , Martino, Rodrigo , Zhang, Mei‐Jie , Bajel, Ashish R. , Battiwalla, Minoo , Bhatt, Vijaya Raj , Cahn, Jean‐Yves , Cutler, Corey S. , Gale, Robert Peter , Grunwald, Michael R. , Koç, Yener , Lazarus, Hillard M. , Lee, Jong Wook , Maertens, Johan A. , McGuirk, Joseph P. , Nishihori, Taiga , Oran, Betül , Schultz, Kirk R. , Lima, Marcos de , Romee, Rizwan , Rashidi, Armin , Stockerl-Goldstein, Keith

Mayo Clinic

Blood Advances | June 14, 2019 | Volume: 3 | Issue: 12 | Pages: 1826-1836

10.1182/bloodadvances.2019000050 | PMID 31201170 Get It

Abstract HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a matched sibling donor (MSD) is still considered the optimal donor. Using the Center for International Blood and Marrow Transplant Research database, we compared outcomes after Haplo-HCT vs MSD in patients with acute myeloid leukemia (AML) in first complete remission (CR1). Data from 1205 adult CR1 AML patients (2008-2015) were analyzed. A total of 336 patients underwent PT-Cy–based Haplo-HCT and 869 underwent MSD using calcineurin inhibitor–based graft-versus-host disease (GVHD) prophylaxis. The Haplo-HCT group included more reduced-intensity conditioning (65% vs 30%) and bone marrow grafts (62% vs 7%), consistent with current practice. In multivariable analysis, Haplo-HCT and MSD groups were not different with regard to overall survival (P = .15), leukemia-free survival (P = .50), nonrelapse mortality (P = .16), relapse (P = .90), or grade II-IV acute GVHD (P = .98). However, the Haplo-HCT group had a significantly lower rate of chronic GVHD (hazard ratio, 0.38; 95% confidence interval, 0.30-0.48; P < .001). Results of subgroup analyses by conditioning intensity and graft source suggested that the reduced incidence of chronic GVHD in Haplo-HCT is not limited to a specific graft source or conditioning intensity. Center effect and minimal residual disease–donor type interaction were not predictors of outcome. Our results indicate a lower rate of chronic GVHD after PT-Cy–based Haplo-HCT vs MSD using calcineurin inhibitor–based GVHD prophylaxis, but similar other outcomes, in patients with AML in CR1. Haplo-HCT is a viable alternative to MSD in these patients.
Detection of Naegleria fowleri, Acanthamoeba spp, and Balamuthia mandrillaris in Formalin-Fixed, Paraffin-Embedded Tissues by Real-Time Multiplex Polymerase Chain Reaction
Norgan, Andrew P. , Sloan, Lynne M., Pritt, Bobbi S. , Pritt, Bobbi S , Norgan, Andrew P

Mayo Clinic

American Journal of Clinical Pathology | June 13, 2019 | Volume: 152 | Issue: 6 | Pages: 799-807

10.1093/ajcp/aqz103 | PMID 31415080 Get It

Abstract Objectives Pathogenic free-living amebae (FLAs) cause skin, ocular, and central nervous system (CNS) infections with significant morbidity and mortality. Diagnosis of FLA infections by pathologic examination of tissue sections can be aided using molecular assays. This study investigated the performance characteristics of a multiplex real-time polymerase chain reaction (PCR) assay (FLA-PCR) for detection and differentiation of FLAs in clinical specimens. Methods FLA-PCR was performed on 39 human specimens comprising one cutaneous, 14 corneal, and 24 CNS formalin-fixed, paraffin-embedded (FFPE) tissues with a histopathologic diagnosis of FLA infection and four CNS FFPE tissues with inflammation but no evidence of FLAs. In addition, clinical specificity and assay limit of detection were determined. Results FLA detection sensitivities ranged from 79% to 84% in FFPE tissues. No cross-reactivity was observed. Conclusions While sensitivity is limited, FLA-PCR assay may serve as a useful adjunct for detection or confirmation of FLA infections in FFPE tissues.
Which Student Characteristics Are Most Important in Determining Clinical Honors in Clerkships? A Teaching Ward Attending Perspective
Herrera, Lauren Nicholas , Schmit, Erinn O. , Willig, James H. , Hoellein, Andrew R., Knudson, Christopher, Law, Karen , Mingioni, Nina , Walsh, Katherine, Estrada, Carlos A. , Williams, Winter , Khodadadi, Ryan B.

Mayo Clinic

Academic Medicine | June 13, 2019 | Volume: 94 | Issue: 10 | Pages: 1581-1588

10.1097/acm.0000000000002836 | PMID 31192796 Get It

Purpose To explore faculty perspectives on which characteristics of high-performing clerkship students are most important when determining an honors or top grade designation for clinical performance. Method In 2016–2017, the authors surveyed faculty (teaching ward attendings) for internal medicine clerkships and 1 pediatrics clerkship in inpatient settings at 5 U.S. academic medical centers. Survey items were framed around competencies, 24 student characteristics, and attitudes toward evaluation. Factor analysis examined constructs defining high-performing students. Results Of 516 faculty invited, 319 (62%) responded. The top 5 characteristics as rated by respondents were taking ownership, clinical reasoning, curiosity, dependability, and high ethical standards (in descending order). Twenty-one characteristics fit into 3 factors (Cronbach alpha, 0.81–0.87). Clinical reasoning did not fit into a factor. Factor 1 was the most important (mean rating, 8.7/10 [95% confidence interval (CI), 8.6–8.8]). It included professionalism components (ownership, curiosity, dependability, high ethical standards), presentation and interviewing skills, seeking feedback, and documentation. Factor 2 (mean, 7.9 [95% CI, 7.7–8.0]) included aspects of teamwork and communication, such as positive attitude and comments from others. Factor 3 (mean, 7.6 [95% CI, 7.4–7.7]) addressed systems-based thinking, including patient safety and care transitions. Conclusions Professionalism components, clinical reasoning, and curiosity were among the most important characteristics distinguishing high-performing clerkship students. These may represent behaviors that are highly valued, observable, and relevant to training stage. Improved definition of the characteristics associated with clinical honors would assist students, faculty, and residency program directors when interpreting clinical performance within core clerkships.
Relationship of Activity Patterns to Acute Mountain Sickness in South Pole Workers
Pathangey, Girish , Wheatley, Courtney M. , Stewart, Glenn M. , Anderson, Paul J., Richert, Maile L. Ceridon, Johnson, Jacob, Johnson, Bruce D., Wheatley-Guy, Courtney M, Johnson, Jacob B, Miller, Andrew D., Pathangey, Girish

Mayo Clinic

International Journal of Sports Medicine | June 12, 2019 | Volume: 40 | Issue: 07 | Pages: 440-446

10.1055/a-0884-3014 | PMID 31189189 Get It

AbstractThis study aimed to evaluate the influence of physical activity on incidence of acute mountain sickness (AMS) by continuous activity monitoring in a free-living sample of South Pole workers over the initial 72 h at altitude exposure of 2,840 m (9,318 ft). Body Media activity monitors were worn by 47 healthy participants. AMS was defined by the Lake Louise symptom questionnaire. Venous blood samples were taken at sea level and approximately 48 h after high altitude exposure. AMS incidence was 34% (n=16/47) over the first 48 h and 40% (n=19/47) over 72 h. On day 2 at high altitude, individuals with AMS demonstrated a significantly greater increase in the percent change in physical activity metrics from baseline: total energy expenditure 19±13 vs. 5±7%, total steps 65±51 vs. 10±18%, metabolic equivalent of tasks 21±13 vs. 7±13%, and time spent performing moderate to vigorous physical activity 114±79 vs. 26±27% for individuals with AMS vs. no AMS, respectively, p<0.05. In addition, erythropoietin and vascular endothelial growth factor were 1.69 and 1.75 times higher, respectively, in those with AMS. In conclusion, workers who engaged in increased physical activity and activity intensity during initial exposure to the South Pole were more susceptible to developing AMS.
TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection
Natesampillai, Sekar, Paim, Ana C. , Cummins, Nathan W. , Chandrasekar, Aswath P. , Bren, Gary D., Lewin, Sharon R. , Badley, Andrew D. , Cummins, Nathan W , Badley, Andrew D , Kiem, Hans‐Peter

Mayo Clinic

The Journal of Immunology | June 12, 2019 | Volume: 203 | Issue: 3 | Pages: 718-724

10.4049/jimmunol.1900271 | PMID 31189571 Get It

Abstract CD4 T cells from HIV-1 infected patients die at excessive rates compared to those from uninfected patients, causing immunodeficiency. We previously identified a dominant negative ligand that antagonizes the TRAIL-dependent pathway of cell death, which we called TRAILshort. Because the TRAIL pathway has been implicated in CD4 T cell death occurring during HIV-1 infection, we used short hairpin RNA knockdown, CRISPR deletion, or Abs specific for TRAILshort to determine the effect of inhibiting TRAILshort on the outcome of experimental acute HIV infection in vitro. Strikingly, all three approaches to TRAILshort deletion/inhibition enhanced HIV-induced death of both infected and uninfected human CD4 T cells. Thus, TRAILshort impacts T cell dynamics during HIV infection, and inhibiting TRAILshort causes more HIV-infected and uninfected bystander cells to die. TRAILshort is, therefore, a host-derived, host-adaptive mechanism to limit the effects of TRAIL-induced cell death. Further studies on the effects of TRAILshort in other disease states are warranted.
PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY
Ulrichsen, Sinna Pilgaard , Larsen, Thomas Stauffer , Himmelstrup, Bodil , Rønnov-Jessen, Dorte, Nowakowski, Grzegorz S. , Thompson, Carrie A. , Madsen, J. , Pedersen, Robert Schou, Gørløv, Jette Sønderskov, d’Amore, Francesco, Clausen, Michael Roost , Maurer, Matthew J. , Link, Brian K. , Feldman, Andrew L. , Slager, Susan L. , Pedersen, Per Trøllund , Cerhan, James R.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 418-420

10.1002/hon.88_2631 Get It

CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Topp, Max S. , Arnason, Jon , Brown, Jennifer R. , Allan, John N. , Ansell, Stephen M. , Duell, Johannes , Rosenwald, Andreas , Charnas, Robert L., Ambati, Srikanth, Adriaens, Lieve, Ufkin, Melanie, Li, J. , Gasparini, Peter, Janković, Vladimir , Fiaschi, Nathalie , Zhang, W., Hamon, Sara , Yancopoulos, George D., Lowy, Israel , Sternberg, David , Advani, Ranjana H. , O’Brien, Susan , Chavez, Julio C , Zhu, Min , Thurston, Gavin , Murphy, Andrew James , Bannerji, Rajat

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 90-92

10.1002/hon.58_2629 Get It